SHANGHAI BLUERAY BIOPHARMA CO LTD has a total of 13 patent applications. Its first patent ever was published in 2018. It filed its patents most often in China, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are HANGZHOU INNOGATE PHARMA CO LTD, MNEMOSYNE PHARMACEUTICALS INC and DAJITI FARMAS JUTIKAL KO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Australia | 1 | |
#4 | EPO (European Patent Office) | 1 | |
#5 | Republic of Korea | 1 | |
#6 | Singapore | 1 | |
#7 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Ma Shichao | 12 |
#2 | Zou Bin | 10 |
#3 | Fu Xianlei | 8 |
#4 | Fu Wencheng | 7 |
#5 | Liu Lanzhen | 7 |
#6 | Xu Shuaijie | 7 |
#7 | Zhang Rui | 6 |
#8 | Zhang Zhongguo | 4 |
#9 | Wang Xiang | 3 |
#10 | Lu Peng | 2 |
Publication | Filing date | Title |
---|---|---|
WO2021032004A1 | Azaheteroaryl compound and application thereof | |
CN111518100A | Cyclopropenoarylbenzofuran substituted nitrogen heteroaryl compound and application thereof | |
AU2019222026A1 | Pyrimidine-fused cyclic compound, preparation method therefor and application thereof | |
WO2019120276A1 | Pyrimidone compound and application thereof | |
CN110734436A | Pyrimidine or pyrazine ring compounds and application thereof | |
CN110655520A | Pyrimido-cyclic compounds, process for their preparation and their use | |
CN110563722A | pyridine or pyridazine ring compound and application thereof |